logo

Tag: GE

Industry

GE Stock on the Rise: A Promising Investment

GE Aerospace’s stock has had a calm market performance. The 1-year high for the company’s stock was $214.21 on 03/26/25, and the lowest price during the same period was recorded at $146.78 on 04/19/24. 52-week price history of GE Stock A stock’s 52-week high and

Industry

GE Aerospace (GE) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. GE Aerospace’s current trading price is -22.23% away from its 52-week high, while its distance from the 52-week low is 13.50%. The stock’s price

News

GE Aerospace (GE) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. GE Aerospace’s current trading price is -0.03% away from its 52-week high, while its distance from the 52-week low is

Finance

GE Aerospace’s: Contrasting Stock Performances in a Volatile Market

The market performance of GE Aerospace’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $212.19 on 02/18/25, while the lowest value for the same duration was $133.99 on 04/02/24. 52-week price history of GE

CSCO Stock
Stock

The Future of GE Aerospace: Analyzing GE

In terms of market performance, GE Aerospace had a fairly even. The highest value for the stock in the past year was $212.19 on 02/18/25, and the lowest value was recorded at $129.98 on 03/12/24. 52-week price history of GE Stock Studying a stock’s 52-week

Equity News

General Electric (GE) Stock Rallies on GE Healthcare Collaboration with GenesisCare

GE Healthcare multi-year strategic partnership is valued at $130 million which includes clinical education and services, imaging technologies, and digital solutions. The stock market is driving towards bullish momentum after the potential COVID-19 vaccine obtaining 90% of completion in final stage trials. However, General Electric